Terminology Service for NFDI4Health
Sunitinib Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C160119
A chemotherapy regimen consisting of sunitinib that may be used in the treatment of soft tissue sarcomas (including alveolar soft part sarcomas); follicular, medullary, papillary, Hurthle cell thyroid carcinomas; thymic carcinomas and thymomas; gastrointestinal stromal tumors (GISTs); kidney and bone cancers; solitary fibrous tumor/hemangiopericytoma; and pancreatic neuroendocrine tumors (NETs). [ ]
Term info
Label
Sunitinib Regimen
Synonyms
- Sunitinib Malate Regimen
- Sunitinib Regimen
- Sutent Regimen
Subsets
NCIT_C160951, NCIT_C160950
Preferred Name
Sunitinib Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C160119
Term relations
Subclass of:
- Chemo(immuno)therapy Regimen Used to Treat Thyroid Cancer
- Regimen Used to Treat Malignant Thymus Neoplasm
- Regimen Used to Treat Malignant Neuroendocrine and Adrenal Neoplasm
- Regimen Used to Treat Malignant Intestinal Neoplasm
- Regimen Used to Treat Malignant Soft Tissue Neoplasm
- Regimen Used to Treat Bone Cancer
- Regimen Used to Treat Sarcoma
- Chemotherapy_Regimen_Has_Component some Sunitinib Malate